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Berberine, an isoquinoline alkaloid extracted from medicinal herbs, has been used as antipyretic, 
antidiarrheal, bactericide and anti-inflammatory agent. In this study, berberine effects on neuronal 
damage have been examined. The right carotid artery of seven-day-old rat pups was ligated (ischemic 
insult), then berberine solution (0.2, 0.5, 1 or 2 mg/kg) was injected intra-peritoneally, and 30 minutes 
later pups were passed through hypoxic condition with breathing in air containing 10% oxygen and 
90% nitrogen(hypoxic insult). The day after that the brains of pups were enucleated for pathologic 
assessment. Pathologic review of the samples obtained from rats treated with different doses of 
berberine in comparison with samples from pups treated by normal saline showed that there was a 
significant reduction of brain injury and edema in the rats treated with berberine. Our study also 
demonstrates that berberine reduces brain ischemic-hypoxic injury dose-dependently. Therefore, 
beberine may be considered as useful anti-stroke agent. 
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Berberine is an isoquinoline alkaloid extracted from medicinal herbs such as Hydrastis 
Canadensis, Rhizoma coptidis and Cortex phellodendri. It is used as antipyretic, 
antidiarrheal and it alleviates stomachache as mentioned in Chinese old medicine (25). 
Nowadays, bactericidal, anti-cholera toxin and anti-inflammation effects of berberine is 
proved. Berberine inhibits cyclooxygenase-2 (COX-2) transcription, reduces local 
interleukin-8 (IL-8) concentration and lipoxygenase activity (6, 7, 23). Also, berberine 
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has been effective in lowering blood glucose and low density lipoprotein cholesterol 
(17). The chemical structure of berberine is shown in Fig. 1. 
 
Fig. 1. Berberine structure formula 
Cerebrovascular accident (CVA) is one of the main causes of death in the world. 
Cellular damage mechanism in relation to CVA is ischemic or hypoxic (8). Following 
to ischemic-hypoxic insult, neuronal cells enter to degenerative process. Immediately 
after ischemic-hypoxic injury the brain may seem normal, grossly and microscopically. 
Little by little, cortex and white matter border decreases. Then, in 12–24 hours 
microscopic changes reveal edema and shrinkage of neurons, eosinophilic cytoplasm, 
nucleus pyknosis and vacuolation of parenchyma. Perivascular and pericellular area 
widens which means vasogenic edema (3). 
Berberine anti-inflammatory effect is explained in many articles. Kuo and his 
colleagues showed that berberine dose dependently decreased production rate of COX-2 
and activator protein-1 in oral cancer cells (6). It has been shown that barberry extract 
reduces neuronal damage in gerbil hippocampus after transient forebrain ischemia (20). 
In this work, we investigated the effect of berberine, one of ingredients of barberry 
extract, on brain injury after hypoxic-ischemic insult. 
Materials and Methods 
Hypoxic-ischemic insult was performed as described by Mahmoudian et al. (10). 
Seven-day-old rat pups of either sex, weighing 10–15 g were used for the experiments. 
They were kept in cages in which their mothers fed them under optimal conditions (4 
pups for each mother). All experiments were approved by the Institute of Animal Care 
Committee at Iran University of Medical Sciences. The pups were categorized in 6 
groups, seven in each. Five groups were operated for ligation of the right carotid artery. 
One group did not undergo any surgery or hypoxic-ischemic insult and served as 
morphologic standard for normal brain tissue. Before operation, the pups were 
anesthetized with ether, and then the right common carotid artery was explored with an 
oblique 5-millimeter incision in front of the neck, and it was ligated with 6-0 surgical 
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silk thread. The incision was sutured with the same thread. After 5 minutes, 0.1 ml of 
the desired solution was injected intraperitoneally. The operated rats were randomly 
divided to five groups. Group 1 (control) received an injection of normal saline, while 
groups 2–5 received 0.2, 0.5, 1.0 and 2 mg/kg berberine in normal saline, respectively. 
All rats were returned to their dams for a 2.5-hour rest and then they were placed in jars 
with mixture of a 10% oxygen and 90% nitrogen circulation and 37±2 °C. After 2.5 
hours, the jars were opened to room air and the surviving pups were returned to their 
dams for 24 hours. Animals were killed and the whole brain was removed and put in 
formalin for three days for neuropathologic assessment. 
To assess the extent of edema and ischemia, the brains were embedded in paraffin 
and 10-mm slices were prepared by a fine microtome from the brain cortex, specially 
hippocampal cortex and basal ganglia. Slides were stained by H&E and examined under 
light microscope by a neuropathologist in a double-blind trial. Ischemic-hypoxic insult 
induced neuronal damage and edema in cortex and basal ganglia was assessed 
according to Rice et al. (15) as follows: 
For edema, grade 0 means no visible swelling, grade 1 means slight swelling, 
grade 2 means moderate swelling and grade 3 means marked swelling. 
For neuronal damage (shrinkage of neurons, eosinophilic cytoplasm, nucleus 
pyknosis and vacuolation of parenchyma), grade 0 means no damage, grade 1 means a 
few neurons damaged, grade 2 means a moderate number of neurons damaged, grade 3 
means the majority of neurons damaged and grade 3+ means infarction (2, 15). 
For statistical analysis, SPSS package was used to carry out one way analyses of 
variance (ANOVA) on the grade of edema and ischemia. 
Results 
The hypoxic-ischemic insult induced edema and ischemia in neonatal rats brains. This 
could be reduced by 0.2–2 mg/kg of berberine (Figs 2 and 3). There is a significant 
difference between berberine-treated groups and normal-saline-treated group. Also, 
groups that receive berberine in higher concentration (1 and 2 mg/kg) showed more 
reduction of ischemic insult in comparison with groups received berberine in lower 
concentrations (0.2 and 0.5 mg/kg). This means that effect of berberine in ameliorating 
ischemic-hypoxic injury is dose-dependent. There was no difference in the effect of 
berberine in cortex and basal ganglia (Fig. 4). 
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Fig. 2. Effect of berberine treatment on neuronal damage 
The injury was evaluated by histological method and graded as described in the text. The control group did 
not have any surgery or hypoxic insult. The insult group received an injection of normal saline after ischemic 
condition. Each region was compared with the similar region (cortex: brick column, basal ganglia: dotted 
column) of the control group. *significant difference (p<0.05) with the insult group in cortex. **significant 
difference (p<0.001) with the insult group in cortex. +significant difference (p<0.05) with the insult group in 
basal ganglia. ++significant difference (p<0.001) with the insult group in basal ganglia 
 
Fig. 3. Effect of berberine treatment on edema 
The injury was evaluated by histological method and graded as described in the text. The control group did 
not have any surgery or hypoxic insult. The insult group received an injection of normal saline after ischemic 
condition. Each region was compared with the similar region (cortex: brick column, basal ganglia: dotted 
column) of the control group. *significant difference (p<0.05) with the insult group in cortex. **significant 
difference (p<0.001) with the insult group in cortex. +significant difference (p<0.05) with the insult group in 
basal ganglia. ++significant difference (p<0.001) with the insult group in basal ganglia 
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Discussion 
Stroke or cerebrovascular accident (CVA) is the third cause of death in USA. Stroke is 
divided to hemorrhagic and infarction types. Cellular damage mechanism in relation to 
CVA is ischemic or hypoxic. Following to ischemic-hypoxic insult, neuronal cells enter 
to degenerative process. Because anaerobic ATP production pathway (glycolysis) along 
with hypoxia persists, ischemia destroys cells sooner than hypoxia. Lack of ATP 
inactivates sodium pumps and glycolysis increases lactic acid concentration, so cells go 
through inflammation and acidosis. Astrocytes take up glucose of the peri-ischemic 
region to store glycolysis substrate for neurons (4, 11). 
The hypoxic-ischemic model used in the present study was developed by Rice et 
al. (15). The model has the advantages of inducing highly-reproducible brain damage in 
spontaneously breathing animals, with low mortality rate, and in the absence of 
convulsions or cardiopulmonary complications for at least the first 50 hours of survival. 
The model is also inexpensive and relatively simple to prepare, so that large numbers of 
predictably brain-damaged animals can be produced for study of drugs. 
Berberine administration to 35 rat pups showed that berberine had an effective 
neuroprotection against ischemic-hypoxic insult. When comparing groups which 
received various doses of berberine with the group which received normal saline, 
groups treated with berberine expressed less injury. Vascular supply of the basal ganglia 
in the rat-brain is variable (16). Ischemic cell necrosis within the basal ganglia may also 
be different. Therefore, case to case variability of the cortical and subcortical cell 
damage is not avoidable. However, we observed a significant reduction in injury in all 
berberine-treated animals. Therefore, we can conclude that berberine reduced ischemic-
hypoxic neuronal damage dose-dependently. 
Berberine anti-inflammatory effect is explained in many articles. Kuo and 
colleagues showed that berberine dose-dependently decreases production rate of COX-2 
and AP-1 in oral cancer cells (6). Oral berberine reduces histological lesions, 
morphological damage, and myeloperoxidase activity in trinitrobenzene sulfonic acid-
induced colitis in rats. Also, berberine can inhibit the increased production of IL-8 in 
trinitrobenzene sulfonic acid-induced colitis in rats (23). Another study in 2007 
demonstrated that berberine, the protoberberine alkaloid widely distributed in the plant 
kingdom, was capable of suppressing inflammatory-agents-induced cytokine production 
in lung cells. These proinflammatory agents are interleukin-1-beta (IL-1-beta) and 
tumor necrosis factor-alpha (TNF-alpha). Moreover, the suppression of berberine on the 
cytokine production resulted from the inhibition of inhibitory kappaB-alpha 
phosphorylation and degradation (7). Ischemia makes cells release substances like 
matrix metalloproteinase which cause secretion of mediators like IL-1-beta and results 
in parenchymal insult (1). Because berberine has anti-inflammatory effect (6), it can 
help to decrease ischemic damage. Some studies have demonstrated the protective 
effect of berberine in cardiac ischemia (19, 22, 24). 
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The main management in ischemic (infarction) type of stroke is thrombolysis to re-
canalize occluded vessels. But this approach has critical side effects such as hemorrhage 
especially in older patients. According to a study in 1995, berberine inhibits platelet 
aggregation and adhesion induced by ADP, arachidonic acid and collagen in rats with 
24 hours of reversible middle cerebral artery occlusion. This study showed that the 
thromboxane B2 (TXB2) levels after drug treatment were lower than those in ischemia 
control rats. Therefore, the decline of platelet aggregation and decrease of TXB2 
content may be one of the important factors involved in the anti-cerebral ischemia effect 
of berberine (18). 
Decreasing of accessible oxygen is hypoxia and decreasing of perfusion means 
ischemia, although differentiating between these two terms is difficult. Brain cortex 
includes perikaryon, dendrites, initial segments of axons and glial cells arranging in 6 
layers. Although neurons in birds’ brain can regenerate, mammals’ neurons usually 
cannot divide and degeneration is irreversible. Among neurons some like hippocampi 
pyramidal cells and globus pallidus neurons are more damageable in relation to 
ischemic-hypoxic insult. This sensitivity is because of increase in glutamic acid and its 
various metabolites in different cells in ischemia. Through ischemic process, other 
components like free radicals increase, then plasma membrane ion is disturbed leading 
to expression of apoptosis genes (3, 8). Berberry extract reduces N-methyl-D-aspartate 
(NMDA) receptor immunoreactivity after ischemia and in this way it reduces neuronal 
damage (20). As berberine has a central sympatholytic effect through alpha 
adrenoceptor blockade (5, 9), its hypotensive effect in stroke patients can have 
disastrous results, since the blood supply to ischemic but as yet uninfarcted brain tissue 
may be further compromised (13). This would be a disadvantage in berberine use for 
stroke patients. 
Many herbs like barberry are overfilled with berberine and have been applied for so 
many years in traditional medicine particularly in China. It seems that berberine has a 
good potential for widespread medical treatment notably in stroke as our research shows. 
We should note that all steps of the study such as adjustment of temperature and 
oxygen concentration were done manually and technical errors are possible. On the 
other hand, observation of the samples for assessing the grade of edema and neuronal 
damage was qualitative, so confounding variables are likely. 
In conclusion, berberine can be used as a neuroprotective agent in ischemia. It is 
relatively non-toxic to humans (14, 21) and its genotoxicity study has shown no 
significant mutagenic effect (12). The most probable neuroprotective mechanism of 
berberine might be due to its anti-inflammatory and anticoagulatory effects. 
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